Chemical Structure : NTRC 0066-0
CAS No.: 1817791-73-3
Catalog No.: PC-61464Not For Human Use, Lab Use Only.
NTRC 0066-0 is a highly potent, selective inhibitor of checkpoint kinase TTK/Mps1 with IC50 of 0.6 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $158 | In stock | |
10 mg | $248 | In stock | |
25 mg | $428 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NTRC 0066-0 is a highly potent, selective inhibitor of checkpoint kinase TTK/Mps1 with IC50 of 0.6 nM.
NTRC 0066-0 displays >200-fold selectivity over 276 kinases, including Aurora C, PLK1, PLK4.
NTRC 0066-0 shows very potent anti-proliferative activity on a broad panel of human cancer cell lines (IC50=18- 897 nM).
NTRC 0066-0 increases the survival in a murine breast cancer model that mimics human TNBC and delays tumor relapse, combined with docetaxel.
M.Wt | 565.722 | |
Formula | C33H39N7O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
8-[2-Methoxy-4-(4-methyl-piperazin-1-yl)-phenylamino]-4,5-dihydro-7,9,9b-triaza-cyclopenta[a]naphthalene-3-carboxylic acid (2,6-diethyl-phenyl)-amide |
1. Maia AR, et al. Ann Oncol. 2015 Oct;26(10):2180-92.
2. Libouban MAA, et al. Oncotarget. 2017 Jun 13;8(24):38309-38325.
3. Zaman GJR, et al. Mol Cancer Ther. 2017 Jul 27. pii: molcanther.0342.2017.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright